John A. MacKay, Synergistic Technologies Associates and Brian C. Smith, Big Sur Scientific discuss the biggest challenges in cannabis related to extraction.
Ken Villazor, President and CEO of Flower One Holdings, recently spoke to us about the large-scale cultivation and production facility they’ve begun operating in Las Vegas.
Arcadia Biosciences, Inc. (Davis, California), an agricultural food ingredient company that is known for leveraging advanced, proprietary breeding techniques to improve the quality and nutritional content of wheat and soybeans, announced that they will apply their expertise cannabis.
GW Pharmaceuticals plc (London, UK and Carlsbad, California) announced the financial results for the last quarter of 2018, which included two months of sales for Epidiolex.
Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.
The Latest Medical Cannabis Research: Dr. Ethan Russo Discusses Neurological Research, Dosing, and More
Dr. Ethan Russo, Director of Research and Development for the International Cannabis and Cannabinoids Institute (ICCI), recently spoke with us about some of his recent research efforts, cannabis dosing, and his continued push to change the stigma against cannabis as a medicine.
Ask the Experts: Cannabis Testing/Analytical Methods, Part I: What Is the Biggest Challenge Facing the Cannabis Industry?
Leading scientists and researchers from the cannabis industry—Bob Clifford, Shimadzu Scientific Instruments; Derek Laine, Trace Analytics; Sandy Mangan, SPEX SamplePrep LLC; Justin Steimling, Restek Corporation; and Katherine Stenerson, M
Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.
President Trump’s nominee for Attorney General, William Barr, stated in his confirmation hearing that he would not go after cannabis companies that were compliant with state laws. In a recent letter in response to written questions from various senators, Barr has put that statement in writing.
We took a look at our most read articles from 2018; here are the top 8.